ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,897, issued on July 15, was assigned to Pfizer Inc. (New York).
"Compounds and method of treating COVID-19" was invented by Robert Steven Kania (Del Mar, Calif.), Dafydd Rhys Owen (Concord, Mass.), Martin Youngjin Pettersson (Littleton, Mass.), Matthew Forrest Sammons (Qunicy, Mass.) and Jamison Bryce Tuttle (Marblehead, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of formula Iwherein R1 and R2 are as defined herein, pharmaceutical compositions comprising the compounds and methods of treating COVID-19 in a patient by administering therapeutically effective amounts of the compounds and methods of inhibiting ...